![Björn Cochlovius](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Björn Cochlovius
Directeur Général chez
Medraxa Therapeutics GmbH
Profil
Dr. Björn Cochlovius is a Chief Executive Officer & Managing Director at Eleva GmbH, an Associate Professor at Ruprecht-Karls-Universität Heidelberg, a Chief Executive Officer at Medraxa Therapeutics GmbH and a General Manager at BC Biomed Consulting GmbH.
Dr. Cochlovius was previously employed as a President by Biocure Technology, Inc., a Chairman by Sapreme Technologies BV, a Chairman by Karolinska Development AB, an Executive Chairman by Isogenica Ltd., a Director-Research & Development by Affitech AS /Old/, a Senior Director-Development by AbbVie, Inc., a Head-Research & Development by Affitech A/S, a Senior Vice President-Business Development by Atriva Therapeutics GmbH, a Chairman & Chief Executive Officer by Ciliatech Therapeutics AG, and a Director-Business Development Oncology by Roche Holding AG.
He received his doctorate degree from Universität des Saarlandes.
Postes actifs de Björn Cochlovius
| Sociétés | Poste | Début |
|---|---|---|
Medraxa Therapeutics GmbH | Directeur Général | - |
BC Biomed Consulting GmbH | Directeur Général | - |
Eleva GmbH
 Eleva GmbH BiotechnologyHealth Technology Develops biotechnology products and services. | Directeur Général | 03/05/2023 |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/05/2003 |
Anciens postes connus de Björn Cochlovius
| Sociétés | Poste | Fin |
|---|---|---|
| KDVENTURES AB | Président | 01/05/2024 |
Sapreme Technologies BV
 Sapreme Technologies BV BiotechnologyHealth Technology Operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics | Président | 01/02/2024 |
| BIOCURE TECHNOLOGY INC. | President | 15/09/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Ciliatech Therapeutics AG
 Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in research, development, production and distribution of pharmaceutical and diagnostic products | Directeur Général | - |
Formation de Björn Cochlovius
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies | Commercial Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität des Saarlandes
 Universität des Saarlandes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eleva GmbH
Eleva GmbH BiotechnologyHealth Technology Develops biotechnology products and services. | Health Technology |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Biocure Technology, Inc.
 Biocure Technology, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Sapreme Technologies BV
Sapreme Technologies BV BiotechnologyHealth Technology Operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics | Health Technology |
Ciliatech Therapeutics AG
Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in research, development, production and distribution of pharmaceutical and diagnostic products | Health Technology |
Medraxa Therapeutics GmbH | |
BC Biomed Consulting GmbH |
Choisissez Zonebourse 
